Medicare Enrolled
Dr. Melody Burt, DO
Family Medicine · Punta Gorda, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Burt from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Burt?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Burt
Dr. Melody Burt is a family medicine specialist in Punta Gorda, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Burt performed 18,581 Medicare services across 10,934 unique beneficiaries.
Between the years covered by Open Payments, Dr. Burt received a total of $9,435 from 58 pharmaceutical and/or device companies across 578 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Burt is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in FL
$9,435 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Osteopathic Physician | 8961 | Clear | March 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗18,581
Medicare services
Top 1% in FL for family medicine
10,934
Unique beneficiaries
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~929 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 1,946 | $86 | $264 |
| Dexamethasone injection (steroid) | 1,855 | $0 | $0 |
| Denosumab injection (Prolia/Xgeva) | 1,500 | $18 | $47 |
| Blood draw (venipuncture) | 1,147 | $8 | $17 |
| Complete blood count (CBC) with differential | 991 | $8 | $16 |
| Comprehensive metabolic blood panel | 974 | $10 | $21 |
| Lipid panel (cholesterol and triglycerides) | 805 | $13 | $27 |
| Thyroid stimulating hormone (TSH) test | 656 | $16 | $34 |
| Free thyroxine (T4) test | 636 | $9 | $18 |
| Creatine kinase (cardiac enzyme) level, total | 608 | $6 | $13 |
| Vitamin B-12 level test | 573 | $15 | $30 |
| Annual wellness visit, follow-up | 537 | $125 | $267 |
| Annual depression screening | 532 | $18 | $38 |
| Hemoglobin A1c test (diabetes monitoring) | 466 | $9 | $19 |
| Electrocardiogram (EKG), 12-lead | 437 | $10 | $30 |
| Automated urinalysis | 397 | $2 | $4 |
| Drug injection, under skin or into muscle | 388 | $10 | $30 |
| Vitamin D level test | 375 | $29 | $59 |
| Injection, methylprednisolone acetate, 80 mg | 282 | $9 | $24 |
| Urine microalbumin test (kidney screening) | 270 | $6 | $12 |
| Creatinine test (kidney function) | 270 | $5 | $10 |
| Uric acid level test | 268 | $4 | $9 |
| Urinalysis with microscopic exam | 267 | $3 | $6 |
| Advance care planning consultation, first 30 min | 251 | $80 | $172 |
| Urine culture, bacterial colony count | 213 | $8 | $16 |
| Flu vaccine administration | 173 | $30 | $64 |
| Flu vaccine, high-dose | 164 | $72 | $144 |
| Ceftriaxone antibiotic injection | 164 | $0 | $1 |
| Prostate cancer screening; prostate specific antigen test (psa) | 160 | $19 | $39 |
| Pneumonia vaccine administration | 137 | $30 | $64 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 111 | $274 | $574 |
| Bacterial culture, aerobic | 72 | $8 | $16 |
| Antibiotic sensitivity test | 72 | $8 | $17 |
| Removal of impacted ear wax | 60 | $33 | $101 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 56 | $35 | $106 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 55 | $1 | $3 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 53 | $18 | $36 |
| Transitional care management services for problem of high complexity | 45 | $210 | $570 |
| Ferritin level test (iron stores) | 44 | $13 | $27 |
| Iron level test | 44 | $6 | $13 |
| Iron binding capacity test | 44 | $9 | $17 |
| Magnesium level test | 44 | $7 | $13 |
| Office visit, established patient, complex (40-54 min) | 39 | $139 | $371 |
| Detection test by immunoassay with direct visual observation for influenza virus | 36 | $16 | $33 |
| Joint injection, major joint | 33 | $51 | $137 |
| Transitional care management services for problem of at least moderate complexity | 29 | $153 | $420 |
| Phosphate level test | 27 | $5 | $9 |
| Office visit, established patient (20-29 min) | 26 | $65 | $187 |
| Basic metabolic blood panel | 25 | $8 | $17 |
| Folic acid level test | 25 | $14 | $29 |
| Sed rate test (inflammation marker) | 24 | $3 | $5 |
| PSA test (prostate cancer screening) | 22 | $18 | $37 |
| C-reactive protein test (inflammation marker) | 21 | $5 | $10 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 19 | $162 | $343 |
| Lipase (fat enzyme) level | 16 | $7 | $14 |
| Testosterone (hormone) level, total | 16 | $25 | $52 |
| Amylase (enzyme) level | 15 | $6 | $13 |
| Pneumococcal conjugate vaccine, 15 valent (pcv15), for intramuscular use | 15 | $241 | $492 |
| Urine culture, bacterial identification | 14 | $8 | $16 |
| New patient office visit (45-59 min) | 13 | $94 | $347 |
| Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | 13 | $8 | $30 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 11 | $38 | $88 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$9,435
Total received (2018-2024)
Avg $1,348/year across 7 years
Top 5% in FL for family medicine
58
Companies
578
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,172 (97.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$264 (2.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,146
2023
$1,845
2022
$1,421
2021
$1,806
2020
$1,128
2019
$960
2018
$1,130
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$1,367
PFIZER INC.
$1,054
GlaxoSmithKline, LLC.
$744
AbbVie Inc.
$579
Amgen Inc.
$576
Lilly USA, LLC
$432
Astellas Pharma US Inc
$406
Merck Sharp & Dohme Corporation
$398
Merck Sharp & Dohme LLC
$359
Janssen Pharmaceuticals, Inc
$292
AstraZeneca Pharmaceuticals LP
$250
Biohaven Pharmaceuticals, Inc.
$223
Boston Scientific Corporation
$222
Boehringer Ingelheim Pharmaceuticals, Inc.
$220
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$210
ABBVIE INC.
$207
Biohaven Pharmaceutical Holding Company Ltd.
$146
Exact Sciences Corporation
$145
Allergan, Inc.
$142
Novartis Pharmaceuticals Corporation
$121
Amarin Pharma Inc.
$118
Takeda Pharmaceuticals U.S.A., Inc.
$91
IBSA Pharma Inc.
$80
Sumitomo Pharma America, Inc.
$78
Eisai Inc.
$72
Abbott Laboratories
$64
Regeneron Healthcare Solutions, Inc.
$62
SANOFI PASTEUR INC.
$59
Esperion Therapeutics, Inc.
$52
Sunovion Pharmaceuticals Inc.
$47
Antares Pharma, Inc.
$39
SANOFI-AVENTIS U.S. LLC
$38
Allergan Inc.
$38
GE HEALTHCARE
$38
EISAI INC.
$36
Currax Pharmaceuticals LLC
$32
AMAG Pharmaceuticals, Inc.
$31
Supernus Pharmaceuticals, Inc.
$30
Corcept Therapeutics
$24
SCILEX PHARMACEUTICALS INC.
$23
Duchesnay USA Incorporated
$21
Axsome Therapeutics, Inc.
$21
Xeris Pharmaceuticals, Inc.
$21
E.R. Squibb & Sons, L.L.C.
$21
GE HealthCare
$19
Inari Medical, Inc.
$18
Phathom Pharmaceuticals, Inc.
$18
Paratek Pharmaceuticals, Inc.
$17
Neuronetics, Inc.
$16
Corium, LLC
$16
Dexcom, Inc.
$15
Nevro Corp.
$15
AbbVie, Inc.
$15
Egalet US Inc
$13
Shire North American Group Inc
$12
Purdue Pharma L.P.
$11
VIVUS, Inc.
$11
FIDIA PHARMA USA INC.
$9
Top 3 companies account for 33.5% of total payments
Associated products mentioned in payments ›
ACCOLADE · ANORO · ANORO ELLIPTA · Adlarity · Aimovig · Auvelity · BASAGLAR · BELSOMRA · BREO · BREZTRI · BREZTRI AEROSPHERE · BYSTOLIC · Belviq · CHANTIX · COMIRNATY · CONTRAVE · CT THROMBECTOMY SYSTEM KIT · Cologuard Collection Kit · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · EVKEEZA · FARXIGA · FLUZONE HIGH-DOSE · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GARDASIL · GARDASIL 9 · GEMTESA · GVOKE HYPOPEN · HYALGAN · INTRAROSA · INVOKANA · JANUVIA · JARDIANCE · KRYSTEXXA · Korlym · LEQVIO · LINZESS · LYRICA · Licart · MOUNJARO · MYFEMBREE · MYRBETRIQ · Myrbetriq · NEUROSTAR TMS THERAPY · NEXLETOL · NOCDURNA · NURTEC ODT · NUZYRA · ONZETRA XSAIL · Osphena · Otezla · Ozempic · PAXLOVID · PNEUMOVAX 23 · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREMARIN · PREVNAR 20 · PVC · Prolia · QELBREE · QSYMIA · QULIPTA · REYVOW · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA 100/33 · SPRIX · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYMPROIC · Saxenda · Senza · Synthroid · TLANDO · TOVIAZ · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tirosint · Trintellix · UBRELVY · VIBERZI · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · WATCHMAN FLX · Wegovy · XARELTO · XIFAXAN · Xultophy 100/3.6 · ZEPBOUND · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for family medicine in FL.
Equivalent to $51 per 100 Medicare services performed
Geographic Context
Family medicine physicians within 10 mi
266
Per 100K population
136.4
County median income
$66,154
Nearest hospital
SHOREPOINT HEALTH PUNTA GORDA
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Burt is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), with low-engagement industry engagement in the top 5% of FL peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Burt experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Burt performed 1,946 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Burt receive payments from pharmaceutical companies?
Yes. Dr. Burt received a total of $9,435 from 58 companies across 578 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Burt's costs compare to other family medicine physicians in Punta Gorda?
Dr. Burt's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Burt) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Punta Gorda
Browse family medicine physicians in Punta Gorda ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in FL
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in FL
Which FL family medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology